The Enterprise Value as of September 2024 (TTM) for Vigil Neuroscience, Inc. (VIGL) is 113.67M

According to Vigil Neuroscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 113.67M. This represents a change of -10.13% compared to the average of 126.48M of the last 4 quarters.

Vigil Neuroscience, Inc. (VIGL) Historical Enterprise Value (quarterly & annually)

How has VIGL Enterprise Value performed in the past?

The mean historical Enterprise Value of Vigil Neuroscience, Inc. over the last ten years is 141.16M. The current 113.67M Enterprise Value has changed 7.95% with respect to the historical average. Over the past ten years (40 quarters), VIGL's Enterprise Value was at its highest in in the June 2023 quarter at 318.85M. The Enterprise Value was at its lowest in in the June 2022 quarter at -75735868.42.

Vigil Neuroscience, Inc. (VIGL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vigil Neuroscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vigil Neuroscience, Inc. (VIGL) Average Enterprise Value

How has VIGL Enterprise Value performed in the past?

The current Enterprise Value of Vigil Neuroscience, Inc. (VIGL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vigil Neuroscience, Inc. (VIGL) Enterprise Value vs. Peers

How is VIGL’s Enterprise Value compared to its peers?

Vigil Neuroscience, Inc.’s Enterprise Value is greater than Molecular Partners AG (-19553835.56), greater than PMV Pharmaceuticals, Inc. (41.44M), less than Monte Rosa Therapeutics, Inc. (300.68M), less than Entrada Therapeutics, Inc. (386.96M), less than Third Harmonic Bio, Inc. (303.08M), less than Cullinan Oncology, Inc. (886.65M), less than Edgewise Therapeutics, Inc. (1.75B), greater than Rallybio Corporation (29.25M), less than PepGen Inc. (255.11M), less than Tyra Biosciences, Inc. (1.13B), less than Compass Therapeutics, Inc. (202.01M), less than PureTech Health plc (248.59M), less than Opthea Limited (544.82M), less than Pharvaris N.V. (643.16M),

Build a custom stock screener for Vigil Neuroscience, Inc. (VIGL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vigil Neuroscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vigil Neuroscience, Inc. (VIGL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vigil Neuroscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.